Quote:

---

Maybe ohm or someone can compare vicroviroc to maraviroc to leronlimab with regards to potential cancer efficacy.

---

In a trial similar to our HIV combo trial vicriviroc had an abysmal 46% efficacy. That suggests a much lower receptor occupancy then leronlimab.